A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, efficacy, and side effects of
beta-D-2,6-diaminopurine dioxolane (DAPD) compared to DAPD plus mycophenolate mofetil (MMF)
when these drugs are added to the anti-HIV treatment regimens of people infected with HIV.
Some studies have shown that DAPD and MMF can help fight HIV. However, neither DAPD nor MMF
has been approved by the Food and Drug Administration for treating HIV infection. This study
will help doctors decide if DAPD and MMF are good drugs for treating HIV.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)